Related Experiment Video
Updated: Feb 7, 2026

Determination of the Photoisomerization Quantum Yield of a Hydrazone Photoswitch
Published on: February 7, 2022
Impairing Powerhouse in Colon Cancer Cells by Hydrazide-Hydrazone-Based Small Molecule
Sohan Patil1, Meenu Mahesh Kuman1, Sandeep Palvai1
1Department of Chemistry, Indian Institute of Science Education and Research (IISER) Pune, Dr. Homi Bhabha Road, Pashan, Pune 411008, India.
Abstract:
Mitochondrion has emerged as one of the unconventional targets in next-generation cancer therapy. Hence, small molecules targeting mitochondria in cancer cells have immense potential in the next-generation anticancer therapeutics. In this report, we have synthesized a library of hydrazide-hydrazone-based small molecules and identified a novel compound that induces mitochondrial outer membrane permeabilization by inhibiting antiapoptotic B-cell CLL/lymphoma 2 (Bcl-2) family proteins followed by sequestration of proapoptotic cytochrome c. The new small molecule triggered programmed cell death (early and late apoptosis) through cell cycle arrest in the G2/M phase and caspase-9/3 cleavage in HCT-116 colon cancer cells, confirmed by an array of fluorescence confocal microscopy, cell sorting, and immunoblotting analysis. Furthermore, cell viability studies have verified that the small molecule rendered toxicity to a panel of colon cancer cells (HCT-116, DLD-1, and SW-620), keeping healthy L929 fibroblast cells unharmed. The novel small molecule has the potential to form a new understudied class of mitochondria targeting anticancer agent.
Insights
Researchers developed a novel small molecule targeting cancer cell mitochondria. This compound induces programmed cell death by affecting B-cell CLL/lymphoma 2 (Bcl-2) proteins and cytochrome c release, showing promise for new anticancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Mitochondria are emerging as key targets for next-generation cancer therapies.
- Small molecules targeting cancer cell mitochondria hold significant therapeutic potential.
- Inhibiting antiapoptotic proteins like B-cell CLL/lymphoma 2 (Bcl-2) can trigger cancer cell death.
Purpose of the Study:
- To synthesize and identify novel hydrazide-hydrazone-based small molecules as potential anticancer agents.
- To investigate the mechanism of action of a novel small molecule targeting cancer cell mitochondria.
- To evaluate the efficacy and selectivity of the identified compound against colon cancer cells.
Main Methods:
- Synthesis of a library of hydrazide-hydrazone-based small molecules.
- Assessment of mitochondrial outer membrane permeabilization and cytochrome c release.
- Analysis of apoptosis induction, cell cycle arrest (G2/M phase), and caspase cleavage (caspase-9/3) in HCT-116 cells.
- Confocal microscopy, cell sorting, and immunoblotting techniques were employed.
- Cell viability assays on various colon cancer cell lines (HCT-116, DLD-1, SW-620) and healthy fibroblast cells (L929).
Main Results:
- A novel small molecule was identified that induces mitochondrial outer membrane permeabilization.
- The compound inhibits antiapoptotic B-cell CLL/lymphoma 2 (Bcl-2) family proteins, leading to cytochrome c sequestration.
- Programmed cell death (apoptosis) and G2/M cell cycle arrest were observed in HCT-116 colon cancer cells.
- The small molecule demonstrated selective toxicity towards colon cancer cells while sparing healthy fibroblast cells.
Conclusions:
- The novel small molecule effectively induces cancer cell death through mitochondrial targeting.
- This compound represents a potential new class of mitochondria-targeting anticancer agents.
- The findings support the development of novel therapeutics focused on mitochondrial pathways in cancer.
Related Concept Videos
The Colonization of Land
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Molecules and Compounds
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Cancer Cell Migration through Invadopodia

